A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MuSK / muscle-specific kinase

[Related PubMed/MEDLINE]
Total Number of Papers: 220
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MuSK  (>> Co-occurring Abbreviation)
Long Form:   muscle-specific kinase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Case of MuSK Myasthenia Gravis Presenting With Persistent Respiratory Insufficiency. MG
2021 Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA). AChRs, NMJ, SMA, SMN
2021 Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common? IgG4-AID
2021 Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. Ig
2021 Improving laboratory diagnostics in myasthenia gravis. AChR, CBAs, LRP4, MG, RIPAs
2021 Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia. CM
2021 Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. AChRs, LRP4, MG
2021 Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders. ASCs, GCs, LLPCs, NMDAR, SLPBs
2021 Timing and localization of myasthenia gravis-related gene expression. AChR, CNS, LRP4, MG
10  2021 Vector-mediated expression of muscle specific kinase restores specific force to muscles in the mdx mouse model of Duchenne muscular dystrophy. AAV-MuSK, TA
11  2021 [A case of elderly-onset myasthenia gravis mimicking stroke with dysarthria and left upper extremity paresis]. MG
12  2020 Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies. AChR, MG
13  2020 ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System. Abs, AChR, MG, NMJ
14  2020 Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program. Abs, AChR, AQP4, CBAs, EQAP, ICN, LPAs, MAG, MOG, NS, OCBs, SPAs, TBAs
15  2020 Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. AChR, LRP4, MG
16  2020 Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. AChR, CIDP, FAE, LRP4, MG, NMJ, NMO, PV
17  2020 Dissecting the Extracellular Complexity of Neuromuscular Junction Organizers. LRP4, NMJ
18  2020 Grave Prognosis of the MuscleSpecific Kinase (MuSK)-positive Myasthenia Gravis (MG): A False Prejudice. MG
19  2020 Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm. AChR-Bi, GAD65, MG, STR
20  2020 Multiple MuSK signaling pathways and the aging neuromuscular junction. ALS, NMJ, SMA
21  2020 Muscle-Specific Kinase Myasthenia Gravis. Ab, AChR, MG
22  2020 MuSK (Muscle Specific Kinase) Positive Myasthenia: Grave Prognosis or Undue Prejudice? ---
23  2020 MuSK antibodies, lessons learned from poly- and monoclonality. MG
24  2020 Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses. MG
25  2020 Successful Transition from Plasma Exchange to Eculizumab in Acetylcholine Receptor Antibody- and Muscle-Specific Kinase (MuSK) Antibody-Negative Myasthenia Gravis: A Case Report. AChR, GMG, MG-ADL, PLEX
26  2019 A Case of Triple-Negative Myasthenia Gravis Lambert-Eaton Overlap Syndrome With Negative Agrin and LRP-4 Antibodies. Ab, AChR, LRP-4, MG, MLOS, VGCC
27  2019 A novel MuSK cell-based myasthenia gravis diagnostic assay. CBA, MG
28  2019 Alternative Splicing and the Intracellular Domain Mediate TM-agrin's Ability to Differentially Regulate the Density of Excitatory and Inhibitory Synapse-like Specializations in Developing CNS Neurons. CNS, LRP4, TM-agrin
29  2019 Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis. MG
30  2019 Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation. AChR, MG, MGFA, RyR
31  2019 Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets. LRP4, MG, nAChR
32  2019 Corrigendum to "Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS" Neurobiology of Disease 124 (2019) 340-352. ---
33  2019 Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis. MG, MuSK MG
34  2019 Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis. ---
35  2019 Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status. Ab, AChR, MG, PLEX
36  2019 First Case of Esophagitis Dissecans Superficialis in an HIV Patient: A Case Report and Literature Review. EDS, MG
37  2019 Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity. ---
38  2019 MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity. AChR, MG
39  2019 Myasthenia gravis. AChR, MG
40  2019 Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. AChR, LRP4, MG, NMJ
41  2019 Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature. AChR, EOM, MG
42  2019 Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential. AChR, MG, NMJ
43  2019 Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG). Ig, IL, MG, MuSK-MG
44  2019 SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody. Abs, MG, SHP2
45  2019 [A case of myasthenia gravis developed during pembrolizumab administration, suggesting an excitation-contraction connection disorder]. AChR, CK
46  2019 [Clinical significance of anti-interferon -alpha2 and anti-interferon -omega antibody in myasthenia gravis]. AChR, IFN, IFN-omega-Ab, LOMG, MG, RIPA, TAMG
47  2018 A 5-Year Follow-Up of Triple-Seronegative Myasthenia Gravis Successfully Treated with Tacrolimus Therapy. AChR, LRP4, MG
48  2018 Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent. AChR, LRP4
49  2018 IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders. MG
50  2018 Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice. AChR, LRP4, M-agrin, MG, N-agrin, NMJ
51  2018 Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence. AChR, LRP4, MG
52  2018 Mild aerobic training with blood flow restriction increases the hypertrophy index and MuSK in both slow and fast muscles of old rats: Role of PGC-1alpha. BFR, CTL, EDL, EX, PGC-1alpha, SH
53  2018 Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS. ALS
54  2018 MuSK myasthenia gravis and pregnancy. ---
55  2018 Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies. AChR, MG
56  2018 Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes. LRP4, MG
57  2018 Recent advances in understanding and managing myasthenia gravis. AChRs, LPR4, MG
58  2018 Serological and experimental studies in different forms of myasthenia gravis. AChR, MG
59  2018 The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis. MG
60  2018 Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. AChR, MG, MGFA, MM, PIS
61  2018 [Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis]. AChR, LRP4, MG
62  2017 Anesthetic Management of a Patient With Antimuscle-Specific Kinase Antibody-Positive Myasthenia Gravis Undergoing an Open Cholecystectomy: A Case Report. MG
63  2017 Comorbid Human Immunodeficiency Virus (HIV) and Muscle-Specific Kinase (MuSK) Myasthenia Gravis: A Case Report and Literature Review. HAART, HIV
64  2017 Emergency Caesarean Section Saved Both an Anti-MuSK Antibody-positive Myasthenia Gravis Mother with Pregnancy-induced Hypertension and Her Premature Baby. CS, MG
65  2017 Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis. CFA, EAMG, NMJs, PBS, TAChR
66  2017 Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis. Abs, LRP4, MG
67  2017 Multiple antibody detection in 'seronegative' myasthenia gravis patients. AChR, LRP4, MG, SNMG
68  2017 Pattern of ocular involvement in myasthenia gravis with MuSK antibodies. MG
69  2017 Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review. MG, MGFA, MGSTI, PIS
70  2017 The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure. ---
71  2017 Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis. ---
72  2016 Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. AChR, MG, RyR
73  2016 Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Abs, AChR, CBA, LRP4, RIA
74  2016 Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis. AChR, BCR, MG
75  2016 Effects of Zusanli and Ashi Acupoint Electroacupuncture on Repair of Skeletal Muscle and Neuromuscular Junction in a Rabbit Gastrocnemius Contusion Model. AChE, EA, GDF8, NGR1, NMJs
76  2016 Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system. AChR, AMPAR, AQP4, CASPR2, LGI1, MOG, NF, NMDAR, VGCC
77  2016 Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis. AChR, MG, NMJ
78  2016 MuSK Kinase Activity is Modulated By A Serine Phosphorylation Site in The Kinase Loop. NMJ
79  2016 Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis. ALS, MG
80  2016 Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. AChR, Ig, LRP4, NMJ
81  2016 The Fibular Nerve Injury Method: A Reliable Assay to Identify and Test Factors That Repair Neuromuscular Junctions. NMJ
82  2015 Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis. AChR, MG, MuSK-EGFP
83  2015 Lrp4 domains differentially regulate limb/brain development and synaptic plasticity. AD, APOE, APP, LDL, Lrp4, NMJ
84  2015 MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study. CBA, MG
85  2015 Myasthenia gravis: subgroup classification and therapeutic strategies. LRP4
86  2015 Preliminary study of genetic diversity and population structure of the Relict Gull Larus relictus (Charadriiformes Laridae) using mitochondrial and nuclear genes. ---
87  2015 Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice. AChR, CFA, COX, MG, MGT, SDH
88  2015 Sorbs1 and -2 Interact with CrkL and Are Required for Acetylcholine Receptor Cluster Formation. AChR
89  2015 Using Xenopus tissue cultures for the study of myasthenia gravis pathogenesis. AChR, ADF, CBA, MG, NMJ
90  2014 Autoantibodies to agrin in myasthenia gravis patients. AChR, LRP4, MG, NMJ
91  2014 B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis. AAb, AChR, MG
92  2014 Cortactin autoantibodies in myasthenia gravis. AChR, LRP4, MG, SNMG, SPMG
93  2014 Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. ---
94  2014 Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy. MG, MuSK-ECD
95  2014 Global analysis of muscle-specific kinase signaling by quantitative phosphoproteomics. ---
96  2014 How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia. AChR, CMS
97  2014 Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction. AChR
98  2014 Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. AChR, MG
99  2014 Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis. AChE, AChR, CTD, MG, NP-MG, PF, PNP, PV, RyR
100  2014 Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis. ALS